الفهرس Only 14 pages are availabe for public view
 |  | from | 147 |  |  |
| | | from | 147 | | |
Abstract
Lymphomas represent the fifth most common cancer diagnosis.
Therapies of lymphomas are moving away from the non-specific cytotoxic
agent, toward more targeted approaches including immunotherapy.
Immunotherapy approaches include monoclonal antibodies either alone or
combined with chemotherapy or radiotherapy and the use of cytokines and
anti-lymphoma vaccines which are still under trial.